AMTB
Amerant Bancorp Inc.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
28.69
▲ 0.25 (0.88%)
MARKET · —
Price
Open
28.61
Prev close
28.44
Day high
28.84
Day low
28.27
Volume
174.47K
Market cap
$1.12B
P/E (TTM)
20.64
52W range
15.62 – 30.60
Trailing performance
Returnvs SPY
1W
-1.65%
-0.3%
1M
+10.99%
+7.3%
3M
+28.08%
+25.0%
6M
+27.00%
+15.9%
YTD
+47.05%
+34.8%
1Y
+42.52%
+22.5%
3Y
+49.58%
-24.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.12B
Enterprise value$1.74B
Revenue (TTM)$391.30M
Gross profit$391.30M
EBITDA—
Net income$56.37M
EPS (TTM)$1.39
Free cash flow—
Total cash$320.31M
Total debt$937.96M
Book value / share$23.34
Shares outstanding39.19M
Float35.25M
Short % of float4.63%
Dividend yield1.25%
Beta (5Y)0.84
Valuation & profitability ratios
Trailing P/E20.64
Forward P/E10.38
PEG ratio—
Price / sales—
Price / book1.23
EV / revenue4.45
EV / EBITDA—
Gross margin0.00%
Operating margin31.68%
Profit margin14.41%
Return on equity6.13%
Return on assets0.55%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $431.40M | $398.66M | $385.49M | $333.94M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $52.42M | -$15.75M | $32.49M | $63.31M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $52.42M | -$15.75M | $32.49M | $63.31M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.39 | 0.52 | +33.4% |
| Mar 2026 | 0.44 | 0.44 | +1.2% |
| Dec 2025 | 0.36 | 0.53 | +49.3% |
| Sep 2025 | 0.53 | 0.39 | -26.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.57 | 4 | $103.27M | -7.5% |
| Next quarter | 0.65 | 4 | $105.19M | -1.6% |
| Current year | 2.19 | 4 | $406.27M | -5.8% |
| Next year | 2.77 | 4 | $434.67M | +7.0% |
Analyst targets & ownership
Mean target$31.88
High target$33.50
Low target$31.00
Implied upside11.10%
Analyst count4
ConsensusBUY
Strong buy / Buy2 / 0
Hold2
Sell / Strong sell0 / 0
Held by insiders3.36%
Held by institutions75.71%
Institutions holding221
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.32M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 21, 26 | CRAGG LEE ANN Officer |
— | 201 | — | Direct |
| Jun 17, 26 | NURSEY MICHAEL E. Officer |
— | 1.34K | — | Direct |
| Jun 1, 26 | CALDERON SHARYMAR Chief Financial Officer |
— | 3.97K | — | Direct |
| May 11, 26 | FLEITAS ARMANDO Officer |
— | 834 | — | Direct |
| May 7, 26 | MARTURET MACHADO GUSTAVO ANTONIO Director |
— | 3.76K | — | Direct |
| May 7, 26 | QUILL JOHN WALTON Director |
— | 3.76K | — | Direct |
| May 7, 26 | SUAREZ OSCAR Director |
— | 3.76K | — | Direct |
| May 7, 26 | KNIGHT ERIN D. Director |
— | 3.76K | — | Direct |
| May 7, 26 | RUCKER ASHAKI Director |
— | 3.76K | — | Direct |
| May 7, 26 | LUTOFF-PERLO LISA A Director |
— | 3.76K | — | Direct |
| May 7, 26 | ALMEIDA ODILON Director |
— | 3.76K | — | Direct |
| May 7, 26 | DANA PAMELLA J Director |
— | 3.76K | — | Direct |
| May 7, 26 | WILSON WILLIAM MILLAR Director |
— | 3.76K | — | Direct |
| Apr 27, 26 | IAFIGLIOLA CARLOS Chief Executive Officer |
BUY | 885 | $20.18K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CALDERON SHARYMAR |
Chief Financial Officer | 20.43K | Conversion of Exercise of derivative security |
CAPRILES ALBERTO |
Officer | 39.28K | Conversion of Exercise of derivative security |
DANA PAMELLA J |
Director | 27.52K | Conversion of Exercise of derivative security |
IAFIGLIOLA CARLOS |
Chief Executive Officer | 21.57K | Purchase |
MARTURET MACHADO GUSTAVO ANTONIO |
Director | 695.11K | Conversion of Exercise of derivative security |
PARRA PEDRO |
Officer | 18.24K | Conversion of Exercise of derivative security |
PLUSH GERALD P |
Chief Executive Officer | 159.44K | Conversion of Exercise of derivative security |
QUILL JOHN WALTON |
Director | 21.08K | Conversion of Exercise of derivative security |
SANCHEZ MARIOLA TRIANA |
Officer | 20.01K | Conversion of Exercise of derivative security |
WILSON WILLIAM MILLAR |
Director | 125.39K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
28.92
-0.80% from price
SMA 20
29.25
-1.91% from price
SMA 50
26.80
+7.04% from price
SMA 100
24.91
+15.19% from price
SMA 200
22.68
+26.50% from price
EMA 12
28.84
-0.51% from price
EMA 26
28.30
+1.37% from price
EMA 50
27.13
+5.77% from price
RSI (14)
55.2
Neutral
MACD (12,26,9)
0.53
Hist -0.25
ATR (14)
0.64
2.22% of price
Realised vol 30D
36.2%
Annualised
Bollinger upper
30.22
20, 2σ
Bollinger lower
28.28
20, 2σ
50 / 200 cross
Golden
26.80 vs 22.68
Trend bias
Above 200
+26.50%
Risk profile
Beta vs SPY
0.72
Less volatile than market
Correlation to SPY
0.30
Largely independent
Realised vol 30D
36.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.9%
Peak to trough
Max drawdown 5Y
-54.8%
Peak to trough
ATR 14
0.64
2.22% of price
Beta (reported)
0.84
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
3.50
Put-heavy session
Put / call open interest
2.33
Positioning, not flow
Max pain
30.00
+4.6% from spot
ATM implied vol
75.7%
Nearest strike to spot
Skew (10% OTM)
-25.0%
Calls bid over puts
Call volume
2
Contracts, this expiry
Put volume
7
Contracts, this expiry
Heaviest call OI
30.00
2 contracts
Heaviest put OI
25.00
5 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Amerant Bancorp Inc. (AMTB) Is Up 0.90% in One Week: What You Should Know
Zacks · 5d ago
Amerant Bank Community Raises Over $100,000 to Support Earthquake Relief Efforts in Venezuela
GlobeNewswire · 11d ago
Are Finance Stocks Lagging EPR Properties (EPR) This Year?
Zacks · 11d ago
Why Amerant Bancorp (AMTB) Might be Well Poised for a Surge
Zacks · 24d ago
Are You Looking for a Top Momentum Pick? Why Amerant Bancorp Inc. (AMTB) is a Great Choice
Zacks · 24d ago
Best Momentum Stock to Buy for July 29th
Zacks · 24d ago
Amerant Bancorp (AMTB) Earnings And Capital Returns Keep Fair Value In View
Simply Wall St. · 27d ago
Amerant Bancorp (AMTB) Stock Sees Fair Value Lift As Analysts Weigh Profitability Reset
Simply Wall St. · 27d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.